Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.

G. Calais | E. Baudin | E. Babin | C. Borel | M. Housset | J. Thariat | G. Poissonnet | V. Costes | S. Testelin | B. Devauchelle | S. Faivre | E. Uro-Coste | P. Herman | F. Chabolle | F. Jegoux | O. Sterkers | G. Dolivet | P. Hofman | X. Leroy | Y. Robin | G. Andry | O. Casiraghi | J. L. St Guily | R. Garrel | X. Dufour | A. Varoquaux | O. Choussy | C. Righini | E. Reyt | D. de Raucourt | É. Serrano | S. Vergez | G. Moulin | S. Duflo | F. Veillon | D. Chevalier | E. de Monès | M. Wassef | A. Bozorg-Grayeli | T. Mom | P. Breton | M. Juliéron | C. Bertolus | L. Crampette | B. Lallemant | J. Michel | P. Dessi | N. Fakhry | T. Radulesco | R. Giorgi | S. Morinière | F. Kolb | L. de Gabory | L. Geoffrois | A. Sudaka | J. Bessede | P. Schultz | R. Jankowski | B. Toussaint | V. Strunski | A. Moya-Plana | G. Noel | L. Gilain | A. Banal | A. Giovanni | T. van den Abbeele | O. Malard | É. Lartigau | O. Mauvais | F. Dubrulle | F. Mouawad | M. Lefèvre | V. Darrouzet | E. Cassagnau | B. Guerrier | J. Mérol | A. Cosmidis | M. Tassart | L. Castillo | F. Rolland | V. Costes-Martineau | B. Ruhin | A. Girod | D. Blanchard | M. Kaminsky | L. Brugel | B. Baujat | C. Bach | E. Coste | C. Ferron | P. Demez | R. Breheret | G. Valette | R. Bensadoun | A. Timochenko | Juan Manuel Monfort Prades Monfort Prades | L. Laccoureye | B. Barry | C. Even | J. Badet | C. Badoual | A. Baglin | S. Hans | J. Chobaut | V. Bastit | P. Lang | P. Ceruse | D. Chevalier | P. Herman | J. Lavieille | L. Le Taillandier de Gabory | A. Coste | L. Dahan | S. Albert | B. Barry | F. Floret | F. Massip | N. Sarroul | M. Lefevre | E. de Mones | J. Bessède

[1]  G. Botti,et al.  Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role , 2018, International journal of molecular sciences.

[2]  J. Vendrell,et al.  Prognostic relevance of insulin resistance on disease‐free survival in head and neck squamous cell carcinomas: Preliminary results , 2017, Head & neck.

[3]  Guevara-Canales Janet-Ofelia,et al.  Mucoepidermoid Carcinoma of the Salivary Glands: Survival and Prognostic Factors , 2017, Journal of Maxillofacial and Oral Surgery.

[4]  W. Mendenhall,et al.  Outcomes after primary or adjuvant radiotherapy for salivary gland carcinoma , 2017, Acta oncologica.

[5]  D. Ghosh,et al.  Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base. , 2016, JAMA otolaryngology-- head & neck surgery.

[6]  T. Padhya,et al.  Multidisciplinary Management of Salivary Gland Cancers. , 2016, Cancer control : journal of the Moffitt Cancer Center.

[7]  R. Weber,et al.  Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma. , 2016, JAMA otolaryngology-- head & neck surgery.

[8]  Y. S. Shin,et al.  Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[9]  F. Janot,et al.  Prise en charge des cancers ORL rares : synthèse des recommandations du réseau d’expertise français REFCOR , 2015, Oncologie.

[10]  W. Mendenhall,et al.  Salivary mucoepidermoid carcinoma revisited , 2015, European Archives of Oto-Rhino-Laryngology.

[11]  Wenjun Yang,et al.  Increased expression of MUC1 predicts poor survival in salivary gland mucoepidermoid carcinoma. , 2014, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[12]  M. Ruan,et al.  Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population. , 2014, International journal of oral and maxillofacial surgery.

[13]  S. Roman,et al.  Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population‐level analysis of 2400 patients , 2014, Head & neck.

[14]  S. Takahashi,et al.  Clinicopathological features of mucoepidermoid carcinoma , 2014, The Journal of Laryngology & Otology.

[15]  D. Farwell,et al.  Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: Clinicopathologic correlates of outcome , 2013, The Laryngoscope.

[16]  P. Bradley,et al.  Incidence of salivary gland neoplasms in a defined UK population. , 2013, The British journal of oral & maxillofacial surgery.

[17]  M. Brandwein-Gensler,et al.  Salivary Mucoepidermoid Carcinoma: A Multi-Institutional Review of 76 Patients , 2013, Head and Neck Pathology.

[18]  T. Carey,et al.  Predictors of Recurrence and Survival for Head and Neck Mucoepidermoid Carcinoma , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[19]  A. Garden,et al.  Prognostic factors in mucoepidermoid carcinoma of the salivary glands , 2012, Cancer.

[20]  Ge Zhou,et al.  Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells , 2011, Cancer.

[21]  P. Pai,et al.  Mucoepidermoid carcinoma of the parotid gland: Factors affecting outcome , 2011, Head & neck.

[22]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[23]  Ehab S Abd-Elhamid,et al.  Image cytometric analysis of p53 and mdm-2 expression in primary and recurrent mucoepidermoid carcinoma of parotid gland: immunohistochemical study , 2010, Diagnostic pathology.

[24]  Simion I. Chiosea,et al.  Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma , 2008, Cancer.

[25]  A. Mäkitie,et al.  Management and Outcome of Patients With Mucoepidermoid Carcinoma of Major Salivary Gland Origin: A Single Institution's 30‐Year Experience , 2008, The Laryngoscope.

[26]  A. Yang,et al.  [Prognostic analysis of 116 patients with mucoepidermoid carcinoma of the parotid gland]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.

[27]  R. Fabian,et al.  Clinical Presentation, Management, and Outcome of High-Grade Mucoepidermoid Carcinoma of the Parotid Gland , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[28]  Young Ho Yun,et al.  Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  L. Thompson.  Mucoepidermoid Carcinoma , 2005, Ear, nose, & throat journal.

[30]  V. Pankratz,et al.  Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. , 2004, Archives of otolaryngology--head & neck surgery.

[31]  P. Speight,et al.  Salivary gland tumours. , 2002, Oral diseases.

[32]  S. Andreola,et al.  Mucoepidermoid carcinoma of the salivary glands: Clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan , 2002, Annals of Surgical Oncology.

[33]  M. Urken,et al.  Mucoepidermoid Carcinoma: A Clinicopathologic Study of 80 Patients With Special Reference to Histological Grading , 2001 .

[34]  G. Ellis,et al.  Mucoepidermoid carcinoma of the major salivary glands , 1998, Cancer.

[35]  R. Schmelzle,et al.  Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients. , 1996, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[36]  G. Ellis,et al.  Mucoepidermoid carcinoma of intraoral salivary glands evaluation and application of grading criteria in 143 cases , 1992, Cancer.

[37]  J. Batsakis,et al.  Histopathologic Grading of Salivary Gland Neoplasms: I. Mucoepidermoid Carcinomas , 1990, The Annals of otology, rhinology, and laryngology.

[38]  L. Vallet.  Desrosières Alain, Thévenot Laurent, Les catégories socio-professionnelles. , 1990 .

[39]  K. H. Perzin,et al.  Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical‐pathologic correlation, and results of treatment , 1970, Cancer.

[40]  V. Pankratz,et al.  Mucoepidermoid Carcinoma of the Parotid Gland , 2016 .

[41]  L. Barnes,et al.  Pathology and genetics of head and neck tumours , 2005 .

[42]  G. Swennen,et al.  Mucoepidermoid carcinoma of the salivary glands--clinical review of 42 cases. , 2005, Oral oncology.

[43]  T. Chan.  World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs , 2005 .

[44]  György Szabó,et al.  Increased prevalence of diabetes and obesity in patients with salivary gland tumors. , 2005, Diabetes care.

[45]  L. Thévenot,et al.  Les catégories socio-professionnelles , 2002 .

[46]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.